CAS RN: 1203499-08-4

1-(5-Bromo-3-nitropyridin-2-yl)piperazine

Product Availability

Choose a grade to view its available package options.

5 package records4 with current stock2 grade groups
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250331 100mg In stock Inquiry
Batchno.20250608 1g In stock Inquiry
Batchno.20251107 250mg In stock Inquiry
Batchno.20250701 5g In stock Inquiry
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20260627 100mg Out of stock 8-10 business days Inquiry
  • Product code: starshine_CAS1203499-08-4
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1203499-08-4 / 1-(5-bromo-3-nitro-2-pyridinyl)piperazine

1-(5-Bromo-3-nitropyridin-2-yl)piperazine | MFCD13176633 | 1-(5-bromo-3-nitro-2-pyridinyl)piperazine

Standard CAS: 1203499-08-4 Multi CAS: No

Basic Information

CAS
1203499-08-4
Multi CAS
No
Molecular Formula
C9H11BrN4O2
Molecular Weight
287.110000
Exact Mass
286.006540
SMILES
C1CN(CCN1)C2=C(C=C(C=N2)Br)[N+](=O)[O-]
InChI
InChI=1S/C9H11BrN4O2/c10-7-5-8(14(15)16)9(12-6-7)13-3-1-11-2-4-13/h5-6,11H,1-4H2
InChIKey
KEICYYFEZSTEIP-UHFFFAOYSA-N
Synonyms
1-(5-Bromo-3-nitropyridin-2-yl)piperazine MFCD13176633 1-(5-bromo-3-nitro-2-pyridinyl)piperazine AKOS005071805 BE-0225

Computed Properties

Structural Parameters

Heavy atom count
16
Aromatic heavy atom count
6
Fraction Csp3
0.44
Rotatable bonds
2
H-bond acceptors
5
H-bond donors
1
Molar refractivity
63.67
TPSA
71.3

LogP / Solubility

WLOGP
1.16
MLOGP
1.03
XLogP3
1.2
Consensus LogP
1.13
Log S (ESOL)
-2.5
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.75
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.73
Class (SILICOS-IT)
Moderately soluble

ADME

GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.65

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
Yes
Synthetic Accessibility
1.5

Get In Touch

Contact Us